Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

THC Biomed Intl Ltd. is a Canada-based cannabis producer. The Company’s principal business is the production and sale of cannabis through THC BioMed Ltd., which is a small batch Licensed Producer as regulated by the Cannabis Act which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company’s biological assets consist of cannabis plants (mother plants and clones for growth); resin; oil; harvested marijuana flowers prior to completion of the drying, grading and testing processes; and edible concentrate. The Company operates in a single reportable segment being the cultivation and sale of cannabis. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho). Clone Shipper Ltd. owns all rights to the Clone Shipper product used to transport live plants.


CSE:THC - Post by User

Bullboard Posts
Comment by fringelifeon Apr 12, 2017 10:10am
76 Views
Post# 26111881

RE:RE:RE:RE:People wondering why they switched to clones

RE:RE:RE:RE:People wondering why they switched to clonesYeah anytime they do math on their revenue, they only take into account home grow and $20 per plant. Except they're forgetting the part where they  plan to sell to other LPs and researchers with an Exemption 56 for a higher premium than patients. This is before the money they will make on Clone Shipper itself. Also, they have shown profit even before they got a license through consulting and training fees. This also includes the service of quality assurance testing.

On top of all this, we know they have a license to sell dried / oils, so it's just a matter of time that they position the company towards that market.

amp7501 wrote: Thing is, everybody and their cab driver wants a HC grow license. To do that you need a plant/product that passes muster. THC has the 29 strains already HC approved. Sure, the business model for home grow is minimal, but for the next few years the commercial clone market to all these new players is ? We will find out, eh?   https://news.lift.co/health-canada-import-cannabis-marijuana/


Bullboard Posts